ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,262.08
1.38%
Dow Jones
44,296.51
0.97%
Gold vs US Dollar
2,715.28
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,373.34
0.60%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Adverum Biotechnologies Inc (ADVM) Share Price

ADVM Adverum Biotechnologies Inc

6.04
0.29 (5.04%)
22 Nov 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Adverum Biotechnologies Inc NASDAQ:ADVM NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.29 5.04 6.04 6.13 6.14 6.15 5.69 5.75 452,237 22:42:08   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics 3.6M -117.17M -5.6323 -1.07 119.61M
 Type  Size  Price  Time  Units 
 9 10 6.14 00:57:14 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ADVM News
20/11/202421:05GLOBEAdverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18/11/202421:05EDGAR2Form 8-K - Current report
18/11/202412:00GLOBEAdverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements
15/11/202421:05GLOBEAdverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements
14/11/202423:57EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14/11/202423:40EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14/11/202421:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Period
Draw mode
Data Downloads for ADVM

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Adverum Biotechnologies Inc Articles

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Silver

1 year 40%, 2 years 50% and *3 years 60%

*Across 3 years £903.96 only 361.58